EMX International

Our diagnostic laser breathalyzer is for unprecedented early detection of lung cancer, breast cancer and other diseases, prior to revelation by CT or MRI.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Melbourne, FL, US
  • Currency USD
  • Founded July 2011
  • Employees 8
  • Incorporation Type LLC
  • Website emxinternational.com

Company Summary

We are an emerging leader in sensor technologies, implementing our patented diagnostic laser breathalyzer in the healthcare marketplace: Detection of lung and breast cancer 8 to 10 years before CT or MRI, early detection of Alzheimer's and Parkinson's disease, unprecedented accuracy, inexpensive, non-invasive, real-time results, proprietary technology, numerous patents issued, renowned staff, new revenue for Doctors, Hospitals, Clinics.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free